"They wanted us to immediately inject $30 million": How the negotiations between Rami Levy and Arkia fell apart
The negotiations between Rami Levy for the acquisition of Arkia collapsed due to Arkia's demand for an immediate injection of $30 million within a month. Ultimately, Ronen Elad acquired control of Arkia, diluting employee holdings from 22% to 15%. Israir CEO Uri Sirkis says a merger between the companies is still appropriate.
The negotiations between Rami Levy, the controlling shareholder of Israir, and Arkia collapsed due to Arkia's urgent need for an immediate injection of $30 million within a month. According to Israir CEO Uri Sirkis, opinions from accounting firms determined that the approval process with the Competition Authority would take too long, and in the meantime Arkia would collapse. Ultimately, businessman Ronen Elad acquired control of Arkia, will inject $30 million and hold 82% of the shares, while the Nakash Group will retain 3% and employee shares will be diluted from 22% to 15%. The employees held talks with other investors, including Ezra Ungar who sought to halt flights on Shabbat, and Ami Cohen of Blue Bird who offered an injection while preserving employee holdings, but his offer came too late. Sirkis clarified that a merger of Israir and Arkia is still right for him, as Israel has six airlines compared to fewer than ten in all of Europe.